J&J Acquires Crystalline Technology Through $230 Mil. TransForm Buy
Executive Summary
Johnson & Johnson will have access to all of TransForm Pharmaceuticals' proprietary crystalline formulation technology through its proposed $230 mil. acquisition of the privately held company